Prevymis (letermovir) - Merck (MSD)
https://pxpro.org/email/2025/ICBMT2025/data/ICBMT2025_abstract_book.pdf
 
Ayako Takarada 1; Naoki Kurita 2, 3; Ryota Ishii 4; Fumiaki Matsumura 3; Kenichi Makishima 3; Sakurako Suma 3; Yuya Sasaki 3; Yasuhito Suehara 2, 3; Keiichiro Hattori 2, 3; Tatsuhiro Sakamoto 2, 3; Takayasu Kato 2, 3; Naoshi Obara 2, 3; Shigeru Chiba 2, 3; Hidekazu Nishikii 2, 3; Mamiko Sakata-Yanagimoto 2, 3
 
Sep 3, 2025
 
Prev Next